These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6507105)

  • 21. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
    Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
    Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
    Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
    Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of a formalin-inactivated Rift Valley fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique.
    Lagerqvist N; Moiane B; Bucht G; Fafetine J; Paweska JT; Lundkvist A; Falk KI
    Vaccine; 2012 Oct; 30(46):6534-40. PubMed ID: 22947138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rift Valley fever vaccine--antibody and immune response in cattle to a live and an inactivated vaccine.
    Barnard BJ
    J S Afr Vet Assoc; 1979 Sep; 50(3):155-7. PubMed ID: 551199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine.
    Morrill JC; Peters CJ
    J Infect Dis; 2011 Aug; 204(4):617-25. PubMed ID: 21791664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep.
    Swanepoel R; Struthers JK; Erasmus MJ; Shepherd SP; McGillivray GM; Shepherd AJ; Hummitzsch DE; Erasmus BJ; Barnard BJ
    J Hyg (Lond); 1986 Oct; 97(2):331-46. PubMed ID: 3537119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.
    Jansen van Vuren P; Tiemessen CT; Paweska JT
    PLoS One; 2011; 6(9):e25027. PubMed ID: 21949840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.
    Wonderlich ER; Caroline AL; McMillen CM; Walters AW; Reed DS; Barratt-Boyes SM; Hartman AL
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29118127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.
    Pittman PR; Norris SL; Brown ES; Ranadive MV; Schibly BA; Bettinger GE; Lokugamage N; Korman L; Morrill JC; Peters CJ
    Vaccine; 2016 Jan; 34(4):523-530. PubMed ID: 26706271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of three candidate Rift Valley fever vaccines in sheep.
    Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
    Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental Rift Valley fever in rhesus macaques.
    Peters CJ; Jones D; Trotter R; Donaldson J; White J; Stephen E; Slone TW
    Arch Virol; 1988; 99(1-2):31-44. PubMed ID: 3355374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of laboratory staff to vaccination with an inactivated Rift Valley fever vaccine--TSI-GSD 200.
    Frank-Peterside N
    Afr J Med Med Sci; 2000 Jun; 29(2):89-92. PubMed ID: 11379456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
    Ikegami T
    Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Infectious, immunogenic, and protective characteristics of the Rift Valley fever virus depending on the passage level and storage conditions].
    Zakutskiy NI; Balysheva VI; Khukhorova I Ju ; Yurkov SG
    Vopr Virusol; 2015; 60(2):41-3. PubMed ID: 26182657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination.
    Wilson WC; Bawa B; Drolet BS; Lehiy C; Faburay B; Jasperson DC; Reister L; Gaudreault NN; Carlson J; Ma W; Morozov I; McVey DS; Richt JA
    Vet Microbiol; 2014 Aug; 172(1-2):44-50. PubMed ID: 24856133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
    Boshra H; Lorenzo G; Rodriguez F; Brun A
    Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in domestic ruminants.
    Paweska JT; Burt FJ; Anthony F; Smith SJ; Grobbelaar AA; Croft JE; Ksiazek TG; Swanepoel R
    J Virol Methods; 2003 Nov; 113(2):103-12. PubMed ID: 14553896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of attenuated strains of Rift Valley fever virus.
    Rossi CA; Turell MJ
    J Gen Virol; 1988 Apr; 69 ( Pt 4)():817-23. PubMed ID: 3356978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
    Näslund J; Lagerqvist N; Habjan M; Lundkvist A; Evander M; Ahlm C; Weber F; Bucht G
    Virology; 2009 Mar; 385(2):409-15. PubMed ID: 19157482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Coxiella burnetii and its chloroform-methanol residue (CMR) fraction against Rift Valley fever virus infection in mice.
    Zvilich M; Williams JC; Waag D; Rill WR; Bell P; Kende M
    Antiviral Res; 1995 May; 27(1-2):137-49. PubMed ID: 7486951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.